Overview
Status
Active
Registry date
2015-02-04
Share capital
1 710 000,00 PLN
Registered address
ul. Eugeniusza Kwiatkowskiego 9, 55-011 Siechnice, Poland
Electronic delivery address
AE:PL-81232-70455-RJHUW-24
Financials
Revenue history (in k)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 261.05MedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD -44.58kMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 21.12kMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 183.27kMedianUSD 541.73kAverageUSD 10.95m
Industry
Bank accounts
Registered as a VAT taxpayer on 2015-03-01. Active
02 1090 1522 0000 0001 2991 4548
63 1090 1522 0000 0001 3673 6042
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Authorized Representatives
Agnieszka Maria Han – Attorney-in-fact (sole)
Maciej Podraza – President of the Management Board
Manner of representation
Each member of the management board is entitled to represent the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 9,560 | $129,119.39 | 27.9532% | |
| 24,640 | $332,793.08 | 72.0468% |
Beneficial owners
| Person | Rights |
|---|---|
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| AsclepiosS.A. | $291,166,555.86 | asclepios.pl | ||
| BaylegS.A. | $86,155,489.09 | bayleg.pl | ||
| NettleS.A. | $85,124,937.06 | nettle.pl | ||
| Centrum Zaopatrzenia Medycznego Cezal - WrocławS.A. | $25,656,815.87 | cezal.com.pl | ||
| Curaleaf PolandS.A. | $2,746,800.02 | can4med.pl | ||
| Zakmed sp. z o.o.sp. k. | $563,217.39 | zakmed.pl | ||
| Beautyeurope.Eu sp. z o.o.sp. k. | $252,179.36 | beautyeurope.eu | ||
| Gierthsp. z o.o. | $240,006.46 | gierth.pl | ||
| Zdrowie Ze Znakiem Kangurasp. z o.o. | $177,221.20 | zdrowie-kangur.pl | ||
| Arjamedicalsp. z o.o. | $29,555.69 | arjamedical.com |
Change history
| Date | Event | |
|---|---|---|
| 2025-11-05 | Share capital change (50,000.00 PLN → 170,000.00 PLN) | |
| 2015-02-04 | Entered in the register |
FAQ
The main business activity of Recepto Pharma focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on February 4, 2015.
The headquarters is located at: ul. Eugeniusza Kwiatkowskiego 9, 55-011 Siechnice.
The management board includes Maciej Podraza (President of the Management Board).
The share capital of the company is PLN 1,710,000 (approx. $461,912).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
In 2025, the company generated total revenue of $261, representing a decrease of 99.0% compared to 2024.
No, the company recorded a net loss of $44,583 in 2025. For comparison, in 2024 the loss was $40,692, meaning the company increased its loss by 9.3%.
The largest operating cost category falls under other operating costs. This category amounted to $15,183 in 2025, representing 72% of all operating expenses.
Last updated: 2026-06-12
